Antibody reactivity of conformational peptide mimics of a conserved H5N1 neutralization site in different fusion proteins

Archives of Virology

Volumn 155, Issue 1, 2010, Pages 19-26

  Zheng, Zhenhua ^a   Luo, Wenxin ^a   Song, Huijuan ^a   Chen, Yingwei ^a   Xiong, Junhui ^a   Chen, Yixin ^a   Gu, Ying ^a   Chen, Honglin ^a   Shih, J Wai Kuo ^a   Zhang, Jun ^a   Xia, Ningshao ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; MONOCLONAL ANTIBODY; PEPTIDE;

ANTIBODY COMBINING SITE; ARTICLE; CHEMISTRY; GENETICS; IMMUNOLOGY; INFLUENZA VIRUS A H5N1; SERODIAGNOSIS;

ANTIBODIES, MONOCLONAL; BINDING SITES, ANTIBODY; INFLUENZA A VIRUS, H5N1 SUBTYPE; NEUTRALIZATION TESTS; PEPTIDES; RECOMBINANT FUSION PROTEINS;

AVIAN INFLUENZA VIRUS; TREPONEMA PALLIDUM;

EID: 75049083912     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-009-0542-2     Document Type: Article

References (39)

1. Ben-Yedidia T, Arnon R (2007) Epitope-based vaccine against influenza. Expert Rev Vaccines 6: 939-948.
2. Binder M, Otto F, Mertelsmann R, Veelken H, Trepel M (2006) The epitope recognized by rituximab. Blood 108: 1975-1978.
3. Casey JL, Coley AM, Street G, Parisi K, Devine PL, Foley M (2006) Peptide mimotopes selected from a random peptide library for diagnosis of Epstein-Barr virus infection. J Clin Microbiol 44: 764-771.
4. Chen Y, Qin K, Wu WL, Li G, Zhang J, Du H, Ng MH, Shih JW, Peiris JS, Guan Y, Chen H, Xia N (2009) Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes. J Infect Dis 199: 49-58.
5. Daly NL, Chen YK, Foley FM, Bansal PS, Bharathi R, Clark RJ, Sommerhoff CP, Craik DJ (2006) The absolute structural requirement for a proline in the P3′-position of Bowman-Birk protease inhibitors is surmounted in the minimized SFTI-1 scaffold. J Biol Chem 281: 23668-23675.
6. Davies JM, Rowley MJ, MacKay IR (1999) Phagotopes derived by antibody screening of phage-displayed random peptide libraries vary in immunoreactivity: studies using an exemplary monoclonal antibody, CII-C1, to type II collagen. Immunol Cell Biol 77: 483-490.
7. De Filette M, Fiers W, Martens W, Birkett A, Ramne A, Lowenadler B, Lycke N, Jou WM, Saelens X (2006) Improved design and intranasal delivery of an M2e-based human influenza A vaccine. Vaccine 24: 6597-6601.
8. Felici F, Luzzago A, Folgori A, Cortese R (1993) Mimicking of discontinuous epitopes by phage-displayed peptides, II. Selection of clones recognized by a protective monoclonal antibody against the Bordetella pertussis toxin from phage peptide libraries. Gene 128: 21-27.
9. Hafner C, Wagner S, Jasinska J, Allwardt D, Scheiner O, Wolff K, Pehamberger H, Wiedermann U, Breiteneder H (2005) Epitope-specific antibody response to Mel-CAM induced by mimotope immunization. J Invest Dermatol 124: 125-131.
10. Hou Y, Gu XX (2003) Development of peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccine candidates. J Immunol 170: 4373-4379.
11. Jensen JK, Malmendal A, Schiott B, Skeldal S, Pedersen KE, Celik L, Nielsen NC, Andreasen PA, Wind T (2006) Inhibition of plasminogen activator inhibitor-1 binding to endocytosis receptors of the low-density-lipoprotein receptor family by a peptide isolated from a phage display library. Biochem J 399: 387-396.
12. Jin Y, Hammer J, Pate M, Zhang Y, Zhu F, Zmuda E, Blazyk J (2005) Antimicrobial activities and structures of two linear cationic peptide families with various amphipathic beta-sheet and alpha-helical potentials. Antimicrob Agents Chemother 49: 4957-4964.
13. Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth B (1998) Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 273: 3718-3724.
14. Karle S, Nishiyama Y, Taguchi H, Zhou YX, Luo J, Planque S, Hanson C, Paul S (2003) Carrier-dependent specificity of antibodies to a conserved peptide determinant of gp120. Vaccine 21: 1213-1218.
15. Konigs C, Rowley MJ, Thompson P, Myers MA, Scealy M, Davies JM, Wu L, Dietrich U, Mackay CR, Mackay IR (2000) Monoclonal antibody screening of a phage-displayed random peptide library reveals mimotopes of chemokine receptor CCR5: implications for the tertiary structure of the receptor and for an N-terminal binding site for HIV-1 gp120. Eur J Immunol 30: 1162-1171.
16. Li SW, Zhang J, He ZQ, Gu Y, Liu RS, Lin J, Chen YX, Ng MH, Xia NS (2005) Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid. J Biol Chem 280: 3400-3406.
17. Liu W, Peng Z, Liu Z, Lu Y, Ding J, Chen YH (2004) High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity. Vaccine 23: 366-371.
18. Luo W, Chen Y, Wang M, Zheng Z, Song H, Chen H, Guan Y, Ng MH, Zhang J, Xia N (2009) Peptide mimics of a conserved H5N1 avian influenza virus neutralization site. Biochem J 419: 133-139.
19. Manea M, Przybylski M, Hudecz F, Mezo G (2008) Design, structural, and immuno-analytical properties of antigenic bioconjugates comprising a beta-amyloid-plaque specific epitope. Biopolymers 90: 94-104.
20. Mezo AR, McDonnell KA, Castro A, Fraley C (2008) Structure-activity relationships of a peptide inhibitor of the human FcRn: human IgG interaction. Bioorg Med Chem 16: 6394-6405.
21. Milich DR, Peterson DL, Zheng J, Hughes JL, Wirtz R, Schodel F (1995) The hepatitis nucleocapsid as a vaccine carrier moiety. Ann N Y Acad Sci 754: 187-201.
22. Nuzzaci M, Piazzolla G, Vitti A, Lapelosa M, Tortorella C, Stella I, Natilla A, Antonaci S, Piazzolla P (2007) Cucumber mosaic virus as a presentation system for a double hepatitis C virus-derived epitope. Arch Virol 152: 915-928.
23. Partidos CD (2000) Peptide mimotopes as candidate vaccines. Curr Opin Mol Ther 2: 74-79.
24. Pini A, Runci Y, Falciani C, Lelli B, Brunetti J, Pileri S, Fabbrini M, Lozzi L, Ricci C, Bernini A, Tonello F, Dal Molin F, Neri P, Niccolai N, Bracci L (2006) Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo. Biochem J 395: 157-163.
25. Riemer AB, Klinger M, Wagner S, Bernhaus A, Mazzucchelli L, Pehamberger H, Scheiner O, Zielinski CC, Jensen-Jarolim E (2004) Generation of peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu. J Immunol 173: 394-401.
26. Rotzschke O, Falk K, Strominger JL (1997) Superactivation of an immune response triggered by oligomerized T cell epitopes. Proc Natl Acad Sci USA 94: 14642-14647.
27. Saphire EO, Montero M, Menendez A, van Houten NE, Irving MB, Pantophlet R, Zwick MB, Parren PW, Burton DR, Scott JK, Wilson IA (2007) Structure of a high-affinity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies. J Mol Biol 369: 696-709.
28. Scott JK, Smith GP (1990) Searching for peptide ligands with an epitope library. Science 249: 386-390.
29. Tschiggerl H, Casey JL, Parisi K, Foley M, Sleytr UB (2008) Display of a peptide mimotope on a crystalline bacterial cell surface layer (S-layer) lattice for diagnosis of Epstein-Barr virus infection. Bioconjug Chem 19: 860-865.
30. Wang H, Gao Y, Gong Y, Chen X, Liu C, Zhou X, Blackall PJ, Zhang P, Yang H (2007) Identification and immunogenicity of an immunodominant mimotope of Avibacterium paragallinarum from a phage display peptide library. Vet Microbiol 119: 231-239.
31. World Health Organization (WHO) (2002) Manual on animal influenza diagnosis and surveillance. WHO, Geneva, Switzerland. http://www. who. int/vaccine_research/diseases/influenza/WHO_manual_on_animal-diagnosis_a nd_surveillance_2002_5. pdf. Accessed 15 Sept 2009.
32. Wu WL, Chen Y, Wang P, Song W, Lau SY, Rayner JM, Smith GJ, Webster RG, Peiris JS, Lin T, Xia N, Guan Y, Chen H (2008) Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007. J Virol 82: 1798-1807.
33. Xiong JH, Guo QS, Ge SX, Gu Y, Chen YX, Miao J, Du HL, Shi WG, Zhang J, Xia NS (2008) The preliminary analysis of the recognition epitopes of anti-HEV monoclonal antibodies on HEV ORF2. Bing Du Xue Bao 24: 83-87.
34. Xu Y, Ramsland PA, Davies JM, Scealy M, Nandakumar KS, Holmdahl R, Rowley MJ (2004) Two monoclonal antibodies to precisely the same epitope of type II collagen select non-crossreactive phage clones by phage display: implications for autoimmunity and molecular mimicry. Mol Immunol 41: 411-419.
35. Yang WJ, Lai JF, Peng KC, Chiang HJ, Weng CN, Shiuan D (2005) Epitope mapping of Mycoplasma hyopneumoniae using phage displayed peptide libraries and the immune responses of the selected phagotopes. J Immunol Methods 304: 15-29.
36. Zelezetsky I, Pacor S, Pag U, Papo N, Shai Y, Sahl HG, Tossi A (2005) Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity. Biochem J 390: 177-188.
37. Zhang J, Gu Y, Ge SX, Li SW, He ZQ, Huang GY, Zhuang H, Ng MH, Xia NS (2005) Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine 23: 2881-2892.
38. Zhang YL, Guo YJ, Wang KY, Lu K, Li K, Zhu Y, Sun SH (2007) Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus. Scand J Immunol 65: 320-328.
39. Zhu ZY, Zhong CP, Xu WF, Lin GM, Ye GQ, Ji YY, Sun B, Yeh M (1999) PSMA mimotope isolated from phage displayed peptide library can induce PSMA specific immune response. Cell Res 9: 271-280.